共 50 条
New Screening Methods in Melanoma
被引:0
|作者:
Czerw, Aleksandra
[1
,2
]
Deptala, Andrzej
[3
]
Partyka, Olga
[1
,2
]
Pajewska, Monika
[1
,2
]
Badowska-Kozakiewicz, Anna
[3
]
Budzik, Michal
[3
]
Sygit, Katarzyna
[4
]
Kopczynski, Zygmunt
[4
]
Czarnywojtek, Piotr
[5
]
Cipora, Elzbieta
[6
]
Konieczny, Magdalena
[6
]
Banas, Tomasz
[7
]
Grochans, Elzbieta
[8
]
Grochans, Szymon
[9
]
Cybulska, Anna Maria
[8
]
Schneider-Matyka, Daria
[8
]
Bandurska, Ewa
[10
]
Ciecko, Weronika
[10
]
Drobnik, Jaroslaw
[11
]
Pobrotyn, Piotr
[12
]
Grata-Borkowska, Urszula
[11
]
Furtak-Pobrotyn, Joanna
[13
]
Sierocka, Aleksandra
[14
]
Marczak, Michal
[15
]
Kozlowski, Remigiusz
[14
]
机构:
[1] Med Univ Warsaw, Dept Hlth Econ & Med Law, PL-01445 Warsaw, Poland
[2] Natl Inst Publ Hlth NIH, Natl Res Inst, Dept Econ & Syst Anal, PL-00791 Warsaw, Poland
[3] Med Univ Warsaw, Dept Oncol Propaedeut, PL-01445 Warsaw, Poland
[4] Calis Univ, Fac Med & Hlth Sci, PL-62800 Kalisz, Poland
[5] Calis Univ, Polytech Fac, PL-62800 Kalisz, Poland
[6] Jan Grodek State Univ Sanok, Med Inst, PL-38500 Sanok, Poland
[7] Mar Sklodowska Curie Natl Res Inst Oncol, Dept Radiotherapy, PL-44102 Krakow, Poland
[8] Pomeranian Med Univ, Fac Hlth Sci, Dept Nursing, PL-71210 Szczecin, Poland
[9] Pomeranian Med Univ, Dept Pediat & Oncol Surg Urol & Hand Surg, Dept Pediat & Oncol Surg Urol & Hand Surg, Szczecin, Poland
[10] Med Univ Gdansk, Ctr Competence Dev Integrated Care & eHlth, PL-80204 Gdansk, Poland
[11] Wroclaw Med Univ, Fac Med, Dept Family Med, PL-51141 Wroclaw, Poland
[12] Pulsantis Specialist & Rehabil Clin Ltd, PL-53238 Wroclaw, Poland
[13] Citodent Dent Ctr Furtak Pobrotyn & Co Ltd Partner, PL-05220 Olawa, Poland
[14] Med Univ Lodz, Dept Management & Logist Healthcare, PL-90131 Lodz, Poland
[15] Merito Univ Poznan, Dept Innovat, PL-61895 Poznan, Poland
来源:
关键词:
melanoma;
MM;
screening;
clinical trials;
RISK;
D O I:
10.3390/cancers16244186
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: The World Health Organisation reports that melanoma had an incidence of 331,722 cases worldwide in 2022, ranking it 17th on the list of the most prevalent malignancies. This disease is a threat to public health as years of potential life lost from melanoma deaths constitute an economic and social burden; it is, however, curable if detected early. This study aims to show current trends in clinical trials for melanoma screening. Materials and Methods: The analysis was conducted using data from clinicaltrials.gov. The analysis considered both interventional and observational studies on melanoma screening. Only the studies with complete and active statutes by 4 September 2024 were included in the analysis. Results: Out of 25 studies registered in clinical trial databases regarding melanoma screening, 20% research advanced imagining techniques employing innovative machine learning algorithms, while 16% explore behavioural interventions. Conclusions: Intensification of behavioural interventions and health promotion activities is recommended.
引用
收藏
页数:10
相关论文